Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Donegan Michael C
Prin. Fin. and Acctg. Officer at TherapeuticsMD. Filing since 11 May 2021.
CIK 0001627810
Company
Date
Role
Action
Shares
Amount
Of holding
TXMD
TherapeuticsMD, Inc.
27 Jan 2023
Prin. Fin. and Acctg. Officer
Sold, plan not stated
49
$249.41
0.4%
TXMD
TherapeuticsMD, Inc.
26 Jan 2023
Prin. Fin. and Acctg. Officer
Sold, plan not stated
1,648
$8.37K
12.2%
TXMD
TherapeuticsMD, Inc.
24 Jan 2023
Prin. Fin. and Acctg. Officer
Sold, plan not stated
7
$37.17
0.1%
TXMD
TherapeuticsMD, Inc.
23 Jan 2023
Prin. Fin. and Acctg. Officer
Sold, plan not stated
1,302
$6.95K
14.6%
TXMD
TherapeuticsMD, Inc.
6 Dec 2022
Interim CFO/CAO/VP of Finance
Sold, plan not stated
910
$4.35K
16.7%
TXMD
TherapeuticsMD, Inc.
30 Nov 2021
CAO and VP of Finance
Sold, plan not stated
29,790
$15.95K
23.1%
TXMD
TherapeuticsMD, Inc.
11 May 2021
CAO and VP Finance
Sold, plan not stated
4,842
$5.04K
25.5%
7 decisions on file.
